Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FPcd86a0fVTVPU5EZECnlXiqh8xE.uncropped.jpg&w=3840&q=75)
Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 13 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.9%
- Check14 days agoChange DetectedDifference0.8%
- Check17 days agoChange DetectedDifference0.8%
- Check18 days agoChange DetectedDifference0.8%
- Check24 days agoChange DetectedThe value on the webpage has changed from 'Acute Graft Versus Host Disease Myeloid Leukemia Acute Non Lymphoblastic Leukemia' to 'Myeloid Leukemia Acute Non Lymphoblastic Leukemia Acute Graft Versus Host Disease'. This change represents a reversal in the order of the conditions listed.SummaryDifference1.0%
Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.